Rheumatology Services
RHEUMADERM provides wide range of Rheumatology Services
Rheumatoid arthritis (RA) is a disease with predominant manifestations involving joints. Extraarticular manifestations appear during the later stages of disease. The onset of manifestations may be acute/intermediate, chronic (insidious) and rarely palindromic. The involvement of joint/s may also vary from single to multiple joints. Monoarticular or oligoarticular, involving one to three joints for substantial period, is less common (1 to 15%) in RA patients. The usual presentation is polyarticular, symmetrical and often having the initial involvement of small joints of hands/feet. The polyarticular presentation accounts for more than 80% of the manifestations. The remaining 10–15% may have non-classical presentations like oligoarticular, predominantly having arthritis of large joints, shoulders and hip. Rarely, the patients may present with dominant extra-articular features like fever, scleritis, vasculitis and carpel tunnel syndrome. Sometimes, the initial presentation may be bursitis and tendinitis. Subsequently, the disease may progress to the remaining joints. RA can present with diverse clinical features but the most common presentation is polyarthritis of small joints.
Spondyloarthropathies or spondyloarthritides are constellation of inflammatory arthritides including ankylosing spondylitis (AS), non-radiographic axial SpA (nr-axSpA), peripheral SpA, reactive arthritis (Reiter’s syndrome), arthritis/spondylitis associated with psoriasis, arthritis/spondylitis associated with inflammatory bowel diseases (IBD) and juvenile onset SpA. There is an overlap of symptoms and complications within this constellation of disorders. Inflammatory back pain, peripheral arthritis, anterior uveitis and enthesitis are the prime clinical features.Patients with psoriasis or IBD may present with skin psoriasis or colitis as presenting symptoms.Manifestations involving other organs are very rare. Most often, there is a lag in time between the onset of symptoms and diagnosis of spondyloarthropathies.
Juvenile idiopathic arthritis (JIA) is the commonest rheumatologic condition that afflicts children. This condition has many subcategories of arthritis included under its umbrella and the presentation of these patients is thus varied.
Systemic Lupus Erythematosus (SLE) is a multisystem prototype autoimmune heterogenous illness characterized by myriad of systemic features primarily due to immune dysregulation at multiple levels of the immune cascade with hyperactivation of B cell activity and diminished T cell suppressor activity leading to increased tissue specific and nontissue specific circulatory antibodies. Having highly variable features like constitutional symptoms, glomerulonephritis, neuropsychiatric disease and cutaneous manifestation SLE is hardly curable, but most of the patients experience remission and their survival has improved over the years.
Sjögren’s syndrome (SS) is an autoimmune epithelitis affecting primarily the exocrine glands and epithelium, characterized by dry eyes and dry mouth. SS can be seen alone (primary SS) or in association with another autoimmune disease like rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) when it is called secondary SS. Prevalence varies from 0.5 to 5%. This is a disease predominantly affecting middle-aged females.
Osteoarthritis (OA) is the commonest joint disease affecting human beings and an important cause of disability. It is a disease of the joint as a whole in which all parts of the joint are involved. There is focal loss of cartilage with accompanying periarticular bone response in the form of subchondral bone sclerosis and attempted new bone formation by way of bony over-growths called osteophytes. This may be preceded by bone marrow oedema and meniscal damage, and may be associated with inflammation of the synovium. OA usually presents, clinically, as joint pain and crepitus in the elderly. Radiologically it is characterised by decreased joint space (cartilage space), osteophytes, eburnation and a variety of deformities that develop as the disease progresses. On MRI it is characterized by presence of bone marrow lesions, meniscal damage, focal cartilage damage, and osteophytes. Its progress is variable and in some patients it is relentless, leading to joint failure (end stage joint disease) necessitating joint replacement.
Osteoporosis is a metabolic bone disease characterized by reduced bone mass and micro-architectural deterioration in bone tissue resulting in an increased susceptibility to fragility fractures. Common sites for fragility fractures are the spine, hip and the wrist. Osteoporosis is a significant public health problem in many parts of the world including India. The importance of osteoporosis can be gauged by the fact that a woman’s lifetime risk of hip fracture equals the combined risk of breast, uterine and ovarian cancers, and the risk of dying from hip fracture equals mortality from breast cancer. Men account for nearly 20–30% of all hip fractures that occur, and one-third of these men do not survive more than a year. The economic consequences of osteoporosis continue to mount as the lifespan of populations around the world increases. The disease, unfortunately, has attracted a little attention and even less action in our country. The effectiveness of treatment strategies currently available mandates that osteoporosis be diagnosed and treated much before the occurrence of complications like fracture.
Gout is characterized by deposition of monosodium urate monohydrate (MSU) in synovial fluid and other tissues. It is the most common form of inflammatory arthritis, with a prevalence of 3.9% in the US,1 0.9% in France,2,3 1.4–2.5% in the UK,4,6 1.4% in Germany,5 and 3.2% (European ancestry)—6.1% (Maori ancestry) in New Zealand.7 The development of gout requires three distinct steps: 1. Long-standing hyperuricaemia, 2. Formation of monosodium urate monohydrate (MSU) crystals and 3. Interaction between MSU crystals and the inflammatory system.